Analysts: Synta Pharmaceuticals Corp (SNTA.OQ)
SNTA.OQ on NASDAQ Stock Exchange Global Market
6.09USD
1 Aug 2013
6.09USD
1 Aug 2013
Price Change (% chg)
$-0.62 (-9.24%)
$-0.62 (-9.24%)
Prev Close
$6.71
$6.71
Open
$6.64
$6.64
Day's High
$6.90
$6.90
Day's Low
$6.04
$6.04
Volume
617,019
617,019
Avg. Vol
463,669
463,669
52-wk High
$11.77
$11.77
52-wk Low
$3.77
$3.77
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.29 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 2 | 2 | 2 | 2 |
| (2) OUTPERFORM | 2 | 1 | 1 | 2 |
| (3) HOLD | 3 | 4 | 4 | 3 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.14 | 2.29 | 2.29 | 2.14 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 8 | 0.32 | 2.60 | 0.00 | 0.50 |
| Quarter Ending Dec-13 | 8 | 1.50 | 9.38 | 0.00 | 0.50 |
| Year Ending Dec-13 | 9 | 1.92 | 9.38 | 0.00 | 8.11 |
| Year Ending Dec-14 | 8 | 7.98 | 53.31 | 0.00 | 32.00 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 8 | -0.29 | -0.21 | -0.36 | -0.32 |
| Quarter Ending Dec-13 | 8 | -0.29 | -0.15 | -0.36 | -0.34 |
| Year Ending Dec-13 | 9 | -1.18 | -0.88 | -1.31 | -1.04 |
| Year Ending Dec-14 | 9 | -1.12 | -0.78 | -1.35 | -0.79 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 0.32 | 0.00 | 0.32 | 100.00 |
| Quarter Ending Dec-12 | 0.45 | 0.00 | 0.45 | 100.00 |
| Quarter Ending Sep-12 | 1.94 | 0.00 | 1.94 | 100.00 |
| Quarter Ending Jun-12 | 0.51 | 0.00 | 0.51 | 100.00 |
| Quarter Ending Mar-12 | 0.66 | 0.15 | 0.51 | 77.71 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | -0.27 | -0.30 | 0.03 | -12.15 |
| Quarter Ending Dec-12 | -0.26 | -0.29 | 0.03 | -10.94 |
| Quarter Ending Sep-12 | -0.23 | -0.25 | 0.02 | -7.76 |
| Quarter Ending Jun-12 | -0.27 | -0.25 | 0.02 | -5.91 |
| Quarter Ending Mar-12 | -0.25 | -0.27 | 0.02 | -9.44 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 0.32 | 0.32 | 0.32 | 0.32 | 0.50 |
| Quarter Ending Dec-13 | 1.50 | 1.50 | 1.50 | 1.50 | 0.50 |
| Year Ending Dec-13 | 1.92 | 1.92 | 1.92 | 1.92 | 8.11 |
| Year Ending Dec-14 | 7.98 | 7.98 | 7.98 | 7.98 | 32.00 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | -0.29 | -0.29 | -0.29 | -0.29 | -0.32 |
| Quarter Ending Dec-13 | -0.29 | -0.29 | -0.29 | -0.29 | -0.34 |
| Quarter Ending Dec-13 | -1.18 | -1.18 | -1.18 | -1.19 | -1.04 |
| Quarter Ending Dec-14 | -1.12 | -1.12 | -1.12 | -1.15 | -0.79 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 1 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Pechala's Reports
|
$25.00
|
|
Provider: Wright Reports
|
$460.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates